Evidence map›Paper›PMID 35384274›Full record

ArticleJournal of biomedical materials research. Part B, Applied biomaterials2022

Amniotic growth factors enhanced human pre-adipocyte cell viability and differentiation under hypoxia.

Alejandro Magana, Regina Giovanni, Edidiong Essien, Boris Epel, Mrignayani Kotecha, Songyun Liu, Mathew T Mathew, Sarah E Hagarty, Divya Bijukumar

Open access · hybridAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part B, Applied biomaterials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Amniotic growth factors enhanced human pre-adipocyte cell viability and differentiation under hypoxia.Journal of biomedical materials research. Part B, Applied biomaterials · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Alejandro MaganaDepartment of Biomedical Science, University of Illinois College of Medicine at Rockford, Rockford, Illinois, USA.
Regina GiovanniDepartment of Biomedical Science, University of Illinois College of Medicine at Rockford, Rockford, Illinois, USA.
Edidiong EssienDepartment of Biomedical Science, University of Illinois College of Medicine at Rockford, Rockford, Illinois, USA.
Boris EpelDepartment of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, USA.
Mrignayani KotechaO2M Technologies, LLC, Chicago, Illinois, USA.
Songyun LiuDepartment of Orthopedics, Rush University of Medical Center, Chicago, Illinois, USA.
Mathew T MathewDepartment of Biomedical Science, University of Illinois College of Medicine at Rockford, Rockford, Illinois, USA.
Sarah E HagartyDepartment of Biomedical Science, University of Illinois College of Medicine at Rockford, Rockford, Illinois, USA.
Divya BijukumarDepartment of Biomedical Science, University of Illinois College of Medicine at Rockford, Rockford, Illinois, USA.ORCID 0000-0001-8114-5444
Illinois College · USHEM Technologies (United States) · USRush University Medical Center · USUniversity of Chicago · US

Funding

Preclinical Oxygen Imager to Model Efficient Cancer TreatmentR44CA224840 · NCI · O2M TECHNOLOGIES, LLC · PI KOTECHA, MRIGNAYANI · 2019 to 2020
$2.3M
Robust Small Animal Oxygen Imager to Model Enhanced Cancer TreatmentR43CA224840 · NCI · O2M TECHNOLOGIES, LLC · PI EPEL, BORIS, KOTECHA, MRIGNAYANI · 2018 to 2018
$358k
Blazer FoundationNational Science Foundation 1819583National Science Foundation 2028829NCI NIH HHS R43 CA224840NCI NIH HHS R44 CA224840NIH HHS R44CA224840the Medical Biotechnology Program of Department of Biomedical Sciences, Rockfordthe OSF St Anthony Hospital Foundation, Office of Research Bridge funding
6 · The paper itself

Abstract

One of the major drawbacks associated with autologous fat grafting is unpredictable graft retention. Various efforts to improve the survivability of these cells have been explored, but these methods are time-consuming, complex, and demand significant technical skill. In our study, we examine the use of cryopreserved amniotic membrane as a source of exogenous growth factors to improve adipocyte survivability under normal and hypoxic conditions. Human primary preadipocytes were cultured in a gelatin-ferulic acid (Gtn-FA) hydrogel with variable oxygen concentration and treated with amniotic membrane-derived condition medium (CM) for 7 days. This hydrogel provides a hypoxic environment and also creates a 3D cell culture to better mimic recipient site conditions. The O

Indexed as

AmnionVascular Endothelial Growth Factor AAdipocytesCell DifferentiationCell SurvivalHumansHydrogelsHypoxiaIntercellular Signaling Peptides and ProteinsOxygenPeroxisome Proliferator-Activated ReceptorsHydrogelsIntercellular Signaling Peptides and ProteinsOxygenPeroxisome Proliferator-Activated ReceptorsVascular Endothelial Growth Factor Aadipocytesamniotic growth factorsfat graftinghypoxiasynergism

Identifiers

PMID35384274
PMCPMC9283253
OpenAlexW4226136215

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.